Delivery Order SPE2DB20D2001-SPE2DB22FM38F
- Not listed
- This federal contract award, valued at $3,245.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of September 16, 2022. This award is associated with a larger Indefinite Delivery Contract...
- This federal contract award, valued at $2,552.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the medication Trulicity 1.5 mg/0.5 ml pen, a treatment for diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp also holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,755.57 delivery order contract is for the supply of the diabetes medication Trulicity 1.5 mg/0.5 ml pen. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which provides...
- This federal contract award, valued at $2,757.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a diabetes medication. This is a delivery order contract with a firm fixed price, and the ultimate completion date is July 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,799.26 Firm Fixed Price Delivery Order is for the supply of Trulicity 1.5 mg/0.5 mL pens, a prescription medication used to manage diabetes. The contract has an ultimate completion date of December 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award, valued at $2,252.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. This is a firm fixed-price delivery order contract with a completion date of November 21, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,952.27 Firm Fixed Price Delivery Order contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract has an ultimate completion date of May 31, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,516.27 firm fixed price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. The contract has an ultimate completion date of May 9, 2025. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $21,654.60 firm fixed-price delivery order is for the supply of Trulicity 3 mg/0.5 ml pens, a medication used to manage diabetes. The contract has an ultimate completion date of September 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award, valued at $5,927.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. This is a firm-fixed-price delivery order contract with a completion date of July 24, 2023. The contract is not associated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB22FM38FDelivery Order
This federal contract award, valued at $3,245.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the medication Trulicity 1.5 mg/0.5 ml pen, which is used to treat diabetes. The contract has an ultimate completion date of January 24, 2022 and utilizes a firm fixed price pricing type. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 1/21/22 |